Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026
PR Newswire —
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Jan. 12, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – The oncology landscape is entering a high-velocity regulatory phase as genomics in cancer care expands toward a projected $69.16 billion by 2032[1]. This massive...